GlassScriptPhysician profile
William F Campbell
NPI 1871799684
$10,050.38
in general payments reported to CMS, 2019-2025
43 companies · $986 in 2025
The $986 reported for 2025 was more than what 82% of Adult Congenital Heart Disease providers received nationally (typical 2025 total: $272).
See the full distribution for Adult Congenital Heart Disease
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,500 · 2020: $807 · 2021: $1,451 · 2022: $2,689 · 2023: $1,507 · 2024: $1,111 · 2025: $986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,603.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $3,811.29 | 2019-2025 | Impella |
| Pfizer INC. | $690.20 | 2019-2025 | |
| Edwards Lifesciences Corporation | $679.32 | 2020-2024 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $608.34 | 2019-2025 | |
| Inari Medical, INC. | $469.82 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $313.36 | 2021-2024 | Xarelto |
| Amgen INC. | $312.64 | 2019-2022 | |
| Penumbra, INC. | $306.29 | 2022-2024 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $238.49 | 2022-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.09 | 2021-2025 | Jardiance |
| Medtronic, INC. | $166.68 | 2021-2024 | Hawkone |
| Irhythm Technologies, INC. | $165.21 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $164.53 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $154.55 | 2019-2025 | Wainua, Farxiga, Brilinta |
| Boston Scientific Corporation | $135.19 | 2023-2025 | Watchman Access System, Rhythmia Mapping System |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $133.56 | 2023 | Lifesparc |
| Lantheus Medical Imaging, INC. | $130.95 | 2019 | |
| Idorsia Pharmaceuticals US INC | $108.16 | 2025 | Tryvio |
| Astellas Pharma US INC | $98.69 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $93.65 | 2022-2025 | Verquvo |
| Shockwave Medical, INC | $91.56 | 2022 | |
| Stryker Corporation | $91.50 | 2025 | Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Actelion Pharmaceuticals US, INC. | $89.94 | 2020-2023 | Uptravi |
| Inspire Medical Systems, INC. | $87.39 | 2024-2025 | Inspire |
| Impulse Dynamics (USA) INC. | $82.47 | 2022-2023 | Optimizer |
| Akcea Therapeutics, INC. | $60.88 | 2019-2020 | |
| Gilead Sciences, INC. | $60.19 | 2019 | |
| Abbott Laboratories | $56.58 | 2021-2022 | |
| Imperative Care, INC | $53.18 | 2025 | Symphony Catheter |
| Alnylam Pharmaceuticals INC. | $48.26 | 2025 | Amvuttra |
| Bridgebio Pharma, INC. | $41.25 | 2025 | Attruby |
| Cardiva Medical, INC. | $41.03 | 2024-2025 | Cardiva Vascade 6/7f Vcs |
| Bayer Healthcare Pharmaceuticals INC. | $39.12 | 2022-2023 | |
| United Therapeutics Corporation | $34.87 | 2025 | Tyvaso |
| Novo Nordisk INC | $30.88 | 2025 | Wegovy |
| Regeneron Healthcare Solutions, INC. | $27.45 | 2025 | Evkeeza |
| Medtronic Vascular, INC. | $25.35 | 2019 | |
| Csl Behring | $22.44 | 2023 | Kcentra |
| Angiodynamics, INC. | $18.06 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $16.67 | 2024 | Arcalyst |
| Becton, Dickinson and Company | $16.12 | 2025 | Fluency Endovascular Stent Graft |
| Chiesi USA, INC. | $13.63 | 2024 | Juxtapid |
| Ge Healthcare | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.